By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LimFlow SA 

9 Rue du 4 Septembre

Paris    75002  France
Phone: 41-79-820-8101 Fax: n/a


LimFlow was founded by the European medical device accelerator MD Start in 2012 and has developed the world’s first system for creating a percutaneous Deep Vein Arterialization of the foot for the treatment of End Stage Critical Limb Ischemia. This is the first ever successfully-completed fully-endovascular approach to achieving venous arterialization of the leg.




Founder and CTO: Tim Lenihan

CEO: Dan Rose

Key Statistics

Ownership: Private

Web Site: LimFlow

Medical Device

Company News
LimFlow Reports Positive pDVA Pilot Trial Data 8/2/2017 8:49:40 AM
LimFlow Announces Publication Of Positive Results From Pilot Study Of Limflow Percutaneous Deep Vein Arterialization (pDVA) System 8/1/2017 7:12:33 AM
LimFlow Announces First Patient Treated In U.S. Feasibility Study And Commencement Of International Post-Market Study 7/11/2017 6:46:42 AM
Europe's LimFlow Hires a COO and Opens Bay Area Office 6/6/2017 12:27:38 PM
LimFlow Receives FDA Approval For U.S. Feasibility Study Of Minimally-Invasive Technology Designed To Restore Perfusion In "No Option" Critical Limb Ischemia Patients 4/26/2017 10:24:19 AM
LimFlow System: A New Option For Treating Critical Limb Ischemia 11/23/2016 7:27:43 AM
LimFlow Receives CE Mark For Purely Percutaneous Critical Limb Ischemia (CLI) Technology Designed To Restore Perfusion For “No Option” Patients 11/15/2016 12:31:35 PM
LimFlow Names Daniel Rose as Chief Executive Officer 10/18/2016 12:18:24 PM